You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 123 No. 4, April 1997 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

Topical Corticosteroid Treatment of Anosmia Associated With Nasal and Sinus Disease

April E. Mott, MD; William S. Cain, PhD; Denis Lafreniere, MD; Gerald Leonard, MD; Janneane F. Gent, PhD; Marion E. Frank, PhD

Arch Otolaryngol Head Neck Surg. 1997;123(4):367-372.


Abstract

Objective
To establish the efficacy of topical corticosteroid nasal spray treatment of severe olfactory loss associated with severe nasal and sinus disease.

Design
Efficacy before and after open-label trial of topical corticosteroid nasal spray used exclusively in the headdown-forward position.

Setting
Taste and smell clinic of a university teaching hospital and research facility.

Patients
Taste and smell clinic patients with anosmia or severe hyposmia associated with paranasal sinus disease and nasal polyposis including 39 of 45 patients recruited from 1988 to 1994 who completed the topical corticosteroid treatment course and returned for subsequent testing.

Intervention
At least 8 weeks of treatment with flunisolide (Nasalide), 2 sprays in each nostril twice a day, with concurrent antibiotic treatment of any bacterial infection.

Main Outcome Measures
Subjective olfactory symptoms, objective olfactory function tests, and otolaryngological evaluation (including endoscopic examination).

Results
Olfactory scores significantly improved following treatment (P<.001); signs of nasal and sinus disease significantly decreased (P<.001); and 26 (66%) of the patients reported a subjective improvement in their sense of smell.

Conclusion
Topical corticosteroid nasal spray administered in a head-down-forward position is an effective treatment of severe olfactory loss associated with severe nasal and sinus disease.

Arch Otolaryngol Head Neck Surg. 1997;123:367-372



Author Affiliations

From the Departments of Medicine (Dr Mott), Surgery (Drs Lafreniere and Leonard), and Biostructure and Function, School of Dental Medicine (Drs Gent and Frank), University of Connecticut Health Center, Farmington; and Department of Surgery, University of California, San Diego, La Jolla (Dr Cain).



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Anti-inflammatory and Surgical Therapy of Olfactory Disorders Related to Sino-nasal Disease
Wolfensberger and Hummel
Chem Senses 2002;27:617-622.
ABSTRACT | FULL TEXT  

The Evaluation and Management of Olfactory Disorder Following Upper Respiratory Tract Infection
Archer
Arch Otolaryngol Head Neck Surg 2000;126:800-802.
FULL TEXT  

Fluctuating Olfactory Sensitivity and Distorted Odor Perception in Allergic Rhinitis
Apter et al.
Arch Otolaryngol Head Neck Surg 1999;125:1005-1010.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1997 American Medical Association. All Rights Reserved.